RELX shares climb again as buyback, AI stay in view

RELX Gains as £200m Buyback Moves Shares Past AI Concerns

June 16, 2026

London, June 16, 2026, 11:04 BST

  • RELX traded between 2,465p and 2,469p in London, rising 0.6% to 0.7%. The gain matched the firmer tone on the FTSE 100. HL
  • RELX is buying back £200 million in shares from June 9 to June 26, part of its £2.25 billion buyback goal set for 2026. Investegate
  • Relx is set to report its half-year results on July 23. Investors are looking for signs that AI-related products can keep up the pace. Relx

RELX PLC gained in London trade on Tuesday, up 15p to 2,465p to sell and 2,466p to buy on Hargreaves Lansdown, a move of 0.61%. AJ Bell had RELX trading 17p higher at 2,467p to 2,469p, a rise of 0.69%. The shares recovered after easing at the start of the week, even though there wasn’t any fresh earnings news out. The FTSE 100 was also up, adding 0.55% on Hargreaves Lansdown, similar to RELX’s climb. HL

RELX relies on buybacks to support the stock at this point. The company said it will repurchase £200 million in ordinary shares between June 9 and June 26, after wrapping up a £150 million buyback that ended June 8. Both buybacks fall under RELX’s £2.25 billion buyback plan for this year. With buybacks, a company reduces its share count, which can lift earnings per share if profits stay flat. Investors are watching that closely. Shares are still trading well under last year’s highs, even though RELX’s profits haven’t changed much. Investegate

RELX’s bullish case still rests on its data and analytics tools and reliable subscription model. The company said it got off to a good start across all four business units in its April trading update, and management is looking for strong growth in underlying revenue and adjusted operating profit again this year. These “underlying” numbers strip out FX swings and M&A. CEO Erik Engstrom told investors back in February: “The continued evolution of artificial intelligence is enabling us to add more value to our customers.” Relx

RELX is still dealing with bearish sentiment. Its legal division, including LexisNexis, draws concern as traders argue over whether large AI models will threaten the pricing of its databases and tools. RELX shares tumbled 14% in February after Anthropic launched new products for legal and professional use, which triggered a fast selloff in data analytics and software, Reuters reported. Later, Reuters Breakingviews said that drop looked overdone, pointing out most RELX revenue is likely safer from AI. But the episode has changed how the market views RELX stock.

RELX trades at a level some investors might call cautiously attractive, not cheap. Hargreaves Lansdown puts its price-to-earnings ratio at 19.08, with a 2.74% dividend yield. The P/E compares share price with annual profit per share. That’s still under the highs when RELX was seen as a defensive data play, but not at distress pricing. Attention turns to July 23, when results for the first half are out. Bulls are watching for growth from legal, risk, and scientific data. If AI rivals start to bite—on renewals, pricing, or costs—the risk to the stock remains. HL

Stock Market Today

  • Genus Shares Rise on China JV and PRP Program Ahead of September Earnings
    June 16, 2026, 6:41 AM EDT. Genus plc shares rose about 0.7%-0.9% in London trade, outperforming the FTSE 250 index. Investor interest centers on Genus's China joint venture (JV) expected to contribute nearly £100 million in Q4 and regulatory progress with its PRRS-resistant pig (PRP) gene-editing program. Institutional investor JNE Partners LLP increased its voting stake above 5%, signaling confidence. Despite a strong H1 with a 38% rise in adjusted operating profit to £55.8 million, valuation at 26.63 times earnings and regulatory risks for PRP in key markets temper bullish sentiment. Analysts see room for share gains with a median 12-month price target of 3,200p, but highlight biotech regulatory uncertainties and market volatility. Full-year results are due September 10.